BRPI0814835A2 - Composição farmacêutica oral de desmopressina - Google Patents

Composição farmacêutica oral de desmopressina

Info

Publication number: BRPI0814835A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; oral pharmaceutical; desmopressin; desmopressin oral; composition
Prior art date: 2007-08-06

Application number

Other languages

English (en)

Inventor

Nuria Carbajal Navarro

Antonio Boix Montañes

Carlos Nieto Abad

Antonio Parente Dueña

Ricard Mis Vicaino

Cesar García Plumed

Original Assignee

Gp Pharm Sa

Reig Jofre S A Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-06

Filing date

2008-08-01

Publication date

2015-03-31

2008-08-01 Application filed by Gp Pharm Sa, Reig Jofre S A Lab filed Critical Gp Pharm Sa

2015-03-31 Publication of BRPI0814835A2 publication Critical patent/BRPI0814835A2/pt

2020-10-27 Publication of BRPI0814835B1 publication Critical patent/BRPI0814835B1/pt

2021-05-25 Publication of BRPI0814835B8 publication Critical patent/BRPI0814835B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Zoology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

BRPI0814835A 2007-08-06 2008-08-01 composição farmacêutica oral de desmopressina e seu uso BRPI0814835B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ESP200702215		2007-08-06
ES200702215A ES2319054B1 (es)	2007-08-06	2007-08-06	Composicion farmaceutica oral de desmopresina.
PCT/ES2008/000539 WO2009027561A2 (es)	2007-08-06	2008-08-01	Composición farmacéutica oral de desmopresina

Publications (3)

Publication Number	Publication Date
BRPI0814835A2 true BRPI0814835A2 (pt)	2015-03-31
BRPI0814835B1 BRPI0814835B1 (pt)	2020-10-27
BRPI0814835B8 BRPI0814835B8 (pt)	2021-05-25

Family

ID=40032884

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0814835A BRPI0814835B8 (pt)	2007-08-06	2008-08-01	composição farmacêutica oral de desmopressina e seu uso

Country Status (18)

Country	Link
US (1)	US8993521B2 (pt)
EP (1)	EP2174652B1 (pt)
JP (1)	JP5626682B2 (pt)
CN (2)	CN101808621A (pt)
AR (1)	AR068337A1 (pt)
BR (1)	BRPI0814835B8 (pt)
CY (1)	CY1118459T1 (pt)
DK (1)	DK2174652T3 (pt)
ES (2)	ES2319054B1 (pt)
HR (1)	HRP20161676T1 (pt)
HU (1)	HUE032667T2 (pt)
LT (1)	LT2174652T (pt)
MX (1)	MX2010001456A (pt)
PL (1)	PL2174652T3 (pt)
PT (1)	PT2174652T (pt)
RU (1)	RU2474414C2 (pt)
SI (1)	SI2174652T1 (pt)
WO (1)	WO2009027561A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO3400B1 (ar)	2010-09-30	2019-10-20	Ferring Bv	مركب صيدلاني من كاربيتوسين
US12214010B2 (en)	2023-04-04	2025-02-04	Tulex Pharmaceuticals Inc.	Desmopressin oral compositions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8306367L (sv)	1983-11-18	1985-05-19	Ferring Ab	Antidiuretiskt verkande farmaceutiskt preparat
ATE108326T1 (de)	1989-01-30	1994-07-15	Corint Ltd	Wässerige desmopressin-cmc enthaltende arzneizubereitung.
JP2653255B2 (ja) *	1990-02-13	1997-09-17	武田薬品工業株式会社	長期徐放型マイクロカプセル
CA2070061C (en)	1991-06-07	2004-02-10	Shigeyuki Takama	Physiologically active polypeptide-containing pharmaceutical composition
US5298256A (en)	1992-04-28	1994-03-29	Corint, Ltd.	Desmopressin buccal patch composition
IT1255460B (it)	1992-07-28	1995-11-02	Poli Ind Chimica Spa	Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
SE9300937L (sv)	1993-03-19	1994-09-20	Anne Fjellestad Paulsen	Komposition för oral administrering av peptider
US5482931A (en)	1993-06-29	1996-01-09	Ferring Ab	Stabilized pharmaceutical peptide compositions
SE9400918L (sv)	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
US5763398A (en)	1996-06-20	1998-06-09	Ferring B.V.	Nasal administration of desmopressin
US20030095926A1 (en) *	1997-10-01	2003-05-22	Dugger Harry A.	Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
HUP0104383A3 (en) *	1998-11-02	2002-12-28	Alza Corp Mountain View	Electrotransport drug delivery device including a compatible antimicrobial agent
US6894026B1 (en)	2000-01-11	2005-05-17	Atossa Healthcare, Inc.	Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
EP1121935B1 (en) *	2000-02-04	2008-08-13	Patents Exploitation Company B.V.	Pharmaceutical composition containing a small or medium size peptide
AT409081B (de) *	2000-02-16	2002-05-27	Gebro Pharma Gmbh	Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
AU2003269747A1 (en) *	2002-05-15	2003-12-02	Sun Pharmaceutical Industries Limited	A stable aqueous composition of a peptide
ITMI20021684A1 (it)	2002-07-29	2004-01-29	Therapicon Srl	Composizione farmaceutica di peptide nasale
WO2004064811A1 (en) *	2003-01-24	2004-08-05	Magle Holding Ab	A composition material for transmucosal delivery
ATE291419T1 (de)	2003-04-30	2005-04-15	Ferring Bv	Feste dosierungsform mit desmopressin
DK1500390T3 (da)	2003-07-25	2005-09-19	Ferring Bv	Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
EP2322198A2 (en)	2003-11-10	2011-05-18	Reprise Biopharmaceutics, LLC	Pharmaceutical compositions including low dosages of desmopressin
GB0406048D0 (en)	2004-03-18	2004-04-21	Ardana Bioscience Ltd	Drug formulations
US20050244502A1 (en)	2004-04-28	2005-11-03	Mathias Neil R	Composition for enhancing absorption of a drug and method

2007
- 2007-08-06 ES ES200702215A patent/ES2319054B1/es active Active
2008
- 2008-08-01 BR BRPI0814835A patent/BRPI0814835B8/pt not_active IP Right Cessation
- 2008-08-01 CN CN200880105631A patent/CN101808621A/zh active Pending
- 2008-08-01 CN CN201610700664.8A patent/CN106265494A/zh active Pending
- 2008-08-01 JP JP2010519481A patent/JP5626682B2/ja not_active Expired - Fee Related
- 2008-08-01 DK DK08805367.3T patent/DK2174652T3/en active
- 2008-08-01 EP EP08805367.3A patent/EP2174652B1/en active Active
- 2008-08-01 US US12/672,255 patent/US8993521B2/en active Active
- 2008-08-01 HR HRP20161676TT patent/HRP20161676T1/hr unknown
- 2008-08-01 WO PCT/ES2008/000539 patent/WO2009027561A2/es not_active Ceased
- 2008-08-01 MX MX2010001456A patent/MX2010001456A/es active IP Right Grant
- 2008-08-01 HU HUE08805367A patent/HUE032667T2/en unknown
- 2008-08-01 PT PT88053673T patent/PT2174652T/pt unknown
- 2008-08-01 PL PL08805367T patent/PL2174652T3/pl unknown
- 2008-08-01 LT LTEP08805367.3T patent/LT2174652T/lt unknown
- 2008-08-01 ES ES08805367.3T patent/ES2608816T3/es active Active
- 2008-08-01 SI SI200831737A patent/SI2174652T1/sl unknown
- 2008-08-01 RU RU2010105031/15A patent/RU2474414C2/ru active
- 2008-08-06 AR ARP080103430A patent/AR068337A1/es not_active Application Discontinuation
2017
- 2017-01-03 CY CY20171100005T patent/CY1118459T1/el unknown

Also Published As

Publication number	Publication date
PT2174652T (pt)	2016-12-23
US20110251123A1 (en)	2011-10-13
ES2319054A1 (es)	2009-05-01
SI2174652T1 (sl)	2017-04-26
RU2010105031A (ru)	2011-09-20
ES2608816T3 (es)	2017-04-17
LT2174652T (lt)	2017-02-27
EP2174652B1 (en)	2016-10-05
DK2174652T3 (en)	2017-01-23
WO2009027561A3 (es)	2009-07-16
RU2474414C2 (ru)	2013-02-10
PL2174652T3 (pl)	2017-06-30
MX2010001456A (es)	2010-06-02
CN106265494A (zh)	2017-01-04
HUE032667T2 (en)	2017-10-30
JP2010535745A (ja)	2010-11-25
HRP20161676T1 (hr)	2017-02-24
AR068337A1 (es)	2009-11-11
US8993521B2 (en)	2015-03-31
WO2009027561A2 (es)	2009-03-05
JP5626682B2 (ja)	2014-11-19
BRPI0814835B1 (pt)	2020-10-27
EP2174652A2 (en)	2010-04-14
ES2319054B1 (es)	2010-02-12
CY1118459T1 (el)	2017-07-12
CN101808621A (zh)	2010-08-18
BRPI0814835B8 (pt)	2021-05-25

Publication	Publication Date	Title
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
LTPA2018014I1 (lt)	2018-12-10	Farmacinė kompozicija 514
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
DK3492069T3 (da)	2022-03-14	Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
BRPI0808889A2 (pt)	2014-11-11	Comprimido desintegrante oral
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
BRPI0920521A2 (pt)	2018-01-16	combinação farmacêutica
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
SMT201700095B (is)	2017-03-08	Composizioni farmaceutiche per inalazione
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
BRPI0812964A2 (pt)	2014-12-16	Forma de dosagem farmacêutica oral sólida
BRPI0912171A2 (pt)	2017-10-31	composição farmacêutica
DK2271321T3 (da)	2012-08-27	Farmaceutisk sammensætning 271
BRPI0921301A2 (pt)	2015-12-29	composição farmacêutica
EP2156832A4 (en)	2010-11-24	PHARMACEUTICAL COMPOSITION
BRPI0814835A2 (pt)	2015-03-31	Composição farmacêutica oral de desmopressina

Legal Events

Date	Code	Title	Description
2017-10-24	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-05-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-07-09	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-12-17	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-03-31	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-10-27	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/10/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/08/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2024-05-28	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 16A ANUIDADE.
2024-09-17	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2786 DE 28-05-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.